Maryland to receive almost $10 million from Mylan over EpiPen charges

Maryland Attorney General Brian Frosh said in a statement the settlement resolves allegations that Mylan demanded "massive" price increases for its EpiPen in the private market and underpaid its EpiPen rebates to Maryland’s Medicaid program.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.